Home Cart 0 Sign in  

[ CAS No. 13726-67-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 13726-67-5
Chemical Structure| 13726-67-5
Structure of 13726-67-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 13726-67-5 ]

Related Doc. of [ 13726-67-5 ]

Alternatived Products of [ 13726-67-5 ]

Product Details of [ 13726-67-5 ]

CAS No. :13726-67-5 MDL No. :MFCD00037279
Formula : C9H15NO6 Boiling Point : -
Linear Structure Formula :- InChI Key :KAJBMCZQVSQJDE-YFKPBYRVSA-N
M.W : 233.22 Pubchem ID :99718
Synonyms :

Calculated chemistry of [ 13726-67-5 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.67
Num. rotatable bonds : 7
Num. H-bond acceptors : 6.0
Num. H-bond donors : 3.0
Molar Refractivity : 53.43
TPSA : 112.93 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.68 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.12
Log Po/w (XLOGP3) : 0.06
Log Po/w (WLOGP) : 0.44
Log Po/w (MLOGP) : -0.07
Log Po/w (SILICOS-IT) : -0.67
Consensus Log Po/w : 0.18

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -0.86
Solubility : 32.1 mg/ml ; 0.137 mol/l
Class : Very soluble
Log S (Ali) : -1.98
Solubility : 2.41 mg/ml ; 0.0104 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.04
Solubility : 213.0 mg/ml ; 0.912 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.9

Safety of [ 13726-67-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 13726-67-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 13726-67-5 ]
  • Downstream synthetic route of [ 13726-67-5 ]

[ 13726-67-5 ] Synthesis Path-Upstream   1~25

  • 1
  • [ 56-84-8 ]
  • [ 24424-99-5 ]
  • [ 13726-67-5 ]
YieldReaction ConditionsOperation in experiment
85%
Stage #1: With sodium hydroxide In 1,4-dioxane; water
Stage #2: at 20℃;
Example 2. Compound 1 (Boc-Asp) (0203) In a 500 mL one-neck round bottom flask, aspartic acid (Asp, 4 g, 30 mmol), 1,4-Dioxane (120 mL) and H2O (60 mL) were mixed yielding a heterogeneous solution. An aqueous solution of NaOH (1 M) was added to the mixture with constant stirring until the solution became homogeneous and clear indicating that the aspartic acid was completely dissolved. The solution was cooled using an ice-bath, then di-tert-butyl dicarbonate (Boc2O, 7.2 g, 33 mmol) dissolved in 1,4-Dioxane (20 mL) was added dropwise. The reaction mixture was then stirred at room temperature overnight. Once the reaction was complete, the solvent was partially evaporated, using a rotary evaporator, to a final volume of 30 mL. Then, EtOAc (20 mL) was added and the water layer was acidified under ice-cold conditions using an aqueous solution of KHSO4 to pH2. The solution mixture was transferred to a separatory funnel and the product was extracted using EtOAc (volume, 3 times). The organic layers were combined and dried over Na2SO4. The solvent was evaporated using rotary evaporator, and further vacuum drying was applied overnight to yield the compound as white solid (6 g; reaction yield85percent). (0204) 1H NMR (600 MHz, DMSO-d6): δ 1.38 (s, 9H), 2.51-2.55 (m, 1H), 2.65-2.69 (m, 1H), 4.24-4.28 (m, 1H), 7.05-7.07 (d, 1H, J=12 Hz), 12.5 (s, 2H).
76.5% With sodium hydroxide In 1,4-dioxane; water at 0 - 20℃; for 5 h; L-aspartic acid (10 g, 0.075 mol) and sodium hydroxide (6.0 g, 0.15 mol) are dissolved in distilled water (100 mL). The solution is cooled in ice bath to 0°C and dioxane (100 mL) was added. (Boc)2O (18.0 g, 0.083 mol) is added dropwise during 1 h. Reaction mixture is stirred in ice bath for 2 hours and then another 2 h at room temperature. Reaction mixture is concentrated on vacuum evaporator. The unreacted (Boc)2O is removed by extraction into the diethyl ether. The aqueous layer is separated, acidified to pH=2 with saturated solution of sodium hydrogen sulfate and the product is extracted into the ethyl acetate. Organic phase is separated, dried with sodium sulfate and concentrated on vacuum evaporator. Boc-L-Asp-OH was crystallized from mixture ethyl acetate/hexane. Yield: 13.4 g (76.5percent), m.p. 116-118°C.
Reference: [1] Journal of the American Chemical Society, 2015, vol. 137, # 51, p. 16084 - 16097
[2] Patent: US2017/168042, 2017, A1, . Location in patent: Paragraph 0203-0204
[3] Asian Journal of Chemistry, 2014, vol. 26, # 15, p. 4716 - 4722
[4] Patent: EP1647283, 2006, A1, . Location in patent: Page/Page column 5
[5] Chemistry Letters, 1988, # 10, p. 1643 - 1646
[6] Tetrahedron Letters, 2001, vol. 42, # 43, p. 7599 - 7603
[7] Tetrahedron, 2007, vol. 63, # 29, p. 6932 - 6937
[8] Synthesis, 2010, # 15, p. 2512 - 2514
[9] Bulletin of the Korean Chemical Society, 2013, vol. 34, # 7, p. 2011 - 2015
  • 2
  • [ 56-84-8 ]
  • [ 13726-67-5 ]
YieldReaction ConditionsOperation in experiment
80% With sodium hydroxide In water; acetonitrile at 25℃; for 15 h; General procedure: L-Phenylalanine (1.0 g, 6.05 mmol) and sodium carbonate (0.71 g, 6.70 mmol) in water (10 mL) was reacted with a solution of 2 (1.89 g, 6.36 mmol) in acetone (10 mL). The reaction mixture was stirred at room temperature till the reaction completes, as monitored by TLC. The resulting solution was concentrated, to the residue was added water (10 mL) and ethyl acetate (10 mL), pH adjusted to 6.0 with 10percent KHSO4 and stirred for 5 minutes. The organic layer was removed and the aqueous layer was acidified to pH 2.0 with 10percent KHSO4 at 0-5°C and extracted with ethyl acetate (2 x 10 mL). The combined organic layers were washed with 5percent NaHCO3 solution, water, brine and dried over anhydrous Na2SO4. The ethyl acetate layer was concentrated and the residue was crystallized from EtOAc/ n-hexane (2:8) mixture to give the product as a white solid (1.53g, 95percent yield).
Reference: [1] Synthetic Communications, 2017, vol. 47, # 22, p. 2127 - 2132
  • 3
  • [ 7536-58-5 ]
  • [ 13726-67-5 ]
Reference: [1] Tetrahedron Letters, 2002, vol. 43, # 2, p. 311 - 313
[2] Organic and Biomolecular Chemistry, 2011, vol. 9, # 8, p. 2597 - 2601
[3] Journal of Organic Chemistry, 1979, vol. 44, p. 3442 - 3444
[4] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2002, vol. 41, # 5, p. 1064 - 1067
[5] Tetrahedron Letters, 2007, vol. 48, # 46, p. 8230 - 8233
[6] Tetrahedron Letters, 1993, vol. 34, # 44, p. 7031 - 7034
  • 4
  • [ 56-84-8 ]
  • [ 98015-52-2 ]
  • [ 13726-67-5 ]
YieldReaction ConditionsOperation in experiment
60% With triethylamine In 1,4-dioxane; water EXAMPLE 28
Synthesis of tert-butyloxycarbonyl-L-aspartic acid
To a solution of 1.33 g (10 mmol) of L-aspartic acid in a dioxane/water (1:1) mixture (30 ml), 4.2 ml (30 mmol) of triethylamine are added, and the mixture is stirred until solution is complete (approximately 10 min).
2.85 g (10 mmol) of tert-butyl 1,2,2,2-tetrachloroethyl carbonate are then added and the mixture is stirred for 6 hours at 20° C. 50 ml of water are then added and the mixture is extracted with 2*20 ml of ethyl acetate.
The aqueous phase is acidified (pH 2-3) with NHCl, and then extracted with 3*30 ml of ethyl acetate.
The extract is washed with saturated NaCl solution, dried over MgSO4 and evaporated.
The product obtained is crystallized in ethyl acetate and petroleum ether. 1.4 g (60percent yield) of the expected acid is obtained. STR60
Reference: [1] Synthesis, 1986, # 8, p. 627 - 632
[2] Journal of Organic Chemistry, 1985, vol. 50, # 20, p. 3951 - 3953
[3] Patent: US4725680, 1988, A,
  • 5
  • [ 116596-40-8 ]
  • [ 13726-67-5 ]
Reference: [1] Journal of Organic Chemistry, 1988, vol. 53, # 22, p. 5386 - 5389
  • 6
  • [ 73821-95-1 ]
  • [ 13726-67-5 ]
Reference: [1] Tetrahedron Letters, 2002, vol. 43, # 2, p. 311 - 313
  • 7
  • [ 56-84-8 ]
  • [ 13726-67-5 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 1989, vol. 62, # 10, p. 3103 - 3108
  • 8
  • [ 56-84-8 ]
  • [ 75844-68-7 ]
  • [ 13726-67-5 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1984, vol. 32, # 6, p. 2174 - 2181
  • 9
  • [ 24424-99-5 ]
  • [ 5269-42-1 ]
  • [ 13726-67-5 ]
Reference: [1] Tetrahedron, 1992, vol. 48, # 16, p. 3377 - 3384
  • 10
  • [ 116596-38-4 ]
  • [ 13726-67-5 ]
Reference: [1] Journal of Organic Chemistry, 1988, vol. 53, # 22, p. 5386 - 5389
  • 11
  • [ 1070-19-5 ]
  • [ 56-84-8 ]
  • [ 13726-67-5 ]
Reference: [1] Chemische Berichte, 1972, vol. 105, # 11, p. 3650 - 3657
[2] Justus Liebigs Annalen der Chemie, 1964, vol. 673, p. 208 - 220
[3] Journal of medicinal chemistry, 1971, vol. 14, # 1, p. 24 - 30
[4] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1977, vol. 15, p. 80 - 81
  • 12
  • [ 149636-02-2 ]
  • [ 13726-67-5 ]
Reference: [1] Tetrahedron Letters, 1993, vol. 34, # 44, p. 7031 - 7034
  • 13
  • [ 24424-99-5 ]
  • [ 13726-67-5 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 1989, vol. 62, # 10, p. 3103 - 3108
[2] Synthetic Communications, 2017, vol. 47, # 22, p. 2127 - 2132
  • 14
  • [ 56-84-8 ]
  • [ 58632-95-4 ]
  • [ 13726-67-5 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 1977, vol. 50, p. 718 - 721
  • 15
  • [ 1043921-06-7 ]
  • [ 100-02-7 ]
  • [ 13726-67-5 ]
Reference: [1] Tetrahedron, 1987, vol. 43, # 1, p. 77 - 84
  • 16
  • [ 18595-55-6 ]
  • [ 56-84-8 ]
  • [ 13726-67-5 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1968, vol. 716, p. 216 - 218
  • 17
  • [ 56-84-8 ]
  • [ 18595-34-1 ]
  • [ 13726-67-5 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1968, vol. 716, p. 175 - 185
  • 18
  • [ 56357-42-7 ]
  • [ 13726-67-5 ]
Reference: [1] Russian Journal of Bioorganic Chemistry, 2000, vol. 26, # 6, p. 361 - 368
  • 19
  • [ 98115-12-9 ]
  • [ 4248-19-5 ]
  • [ 13726-67-5 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1986, vol. 34, # 8, p. 3506 - 3509
  • 20
  • [ 156589-19-4 ]
  • [ 13726-67-5 ]
Reference: [1] Synthesis, 1993, # 12, p. 1261 - 1266
  • 21
  • [ 13726-67-5 ]
  • [ 100-51-6 ]
  • [ 7536-58-5 ]
Reference: [1] Tetrahedron, 2016, vol. 72, # 13, p. 1706 - 1715
  • 22
  • [ 13726-67-5 ]
  • [ 100-51-6 ]
  • [ 30925-18-9 ]
Reference: [1] Tetrahedron, 1987, vol. 43, # 8, p. 1823 - 1826
[2] Journal of Medicinal Chemistry, 1973, vol. 16, p. 624 - 629
  • 23
  • [ 13726-67-5 ]
  • [ 104227-71-6 ]
Reference: [1] Synlett, 2003, # 6, p. 797 - 800
  • 24
  • [ 13726-67-5 ]
  • [ 128427-10-1 ]
Reference: [1] Tetrahedron Letters, 2001, vol. 42, # 43, p. 7599 - 7603
  • 25
  • [ 13726-67-5 ]
  • [ 83345-44-2 ]
Reference: [1] Synlett, 2003, # 6, p. 797 - 800
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 13726-67-5 ]

Amino Acid Derivatives

Chemical Structure| 41088-86-2

[ 41088-86-2 ]

Boc-L-Homoserine

Similarity: 0.98

Chemical Structure|

[ ]

Similarity: 0.98

Chemical Structure| 124184-67-4

[ 124184-67-4 ]

Boc-D-Asp(OMe)-OH

Similarity: 0.96

Chemical Structure| 59768-74-0

[ 59768-74-0 ]

Boc-Asp(OMe)-OH

Similarity: 0.96

Chemical Structure| 34306-42-8

[ 34306-42-8 ]

Boc-Abu-OH

Similarity: 0.96